The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(Piperidin-1-yl)ethyl 4-(4-((5-chloro-4-((2-(methylcarbamoyl)phenyl)amino)pyrimidin-2-yl)amino)benzoyl)piperazine-1-carbodithioate ID: ALA4559783
PubChem CID: 155557866
Max Phase: Preclinical
Molecular Formula: C31H37ClN8O2S2
Molecular Weight: 653.28
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCN4CCCCC4)CC3)cc2)ncc1Cl
Standard InChI: InChI=1S/C31H37ClN8O2S2/c1-33-28(41)24-7-3-4-8-26(24)36-27-25(32)21-34-30(37-27)35-23-11-9-22(10-12-23)29(42)39-15-17-40(18-16-39)31(43)44-20-19-38-13-5-2-6-14-38/h3-4,7-12,21H,2,5-6,13-20H2,1H3,(H,33,41)(H2,34,35,36,37)
Standard InChI Key: DBZXJKBZMWSTGM-UHFFFAOYSA-N
Molfile:
RDKit 2D
44 48 0 0 0 0 0 0 0 0999 V2000
36.7722 -27.5492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7710 -28.3687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4791 -28.7777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1888 -28.3683 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.1859 -27.5456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4773 -27.1404 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.8921 -27.1344 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.6013 -27.5403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0644 -27.1408 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.3568 -27.5496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6491 -27.1394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9420 -27.5475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9417 -28.3655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6545 -28.7738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3587 -28.3634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6011 -28.3551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3095 -28.7610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0166 -28.3497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0109 -27.5283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3019 -27.1261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.7264 -28.7547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.7306 -29.5718 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
42.4320 -28.3425 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.1387 -28.7531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.8422 -28.3444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.8423 -27.5268 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.1326 -27.1197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.4229 -27.5301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6498 -26.3222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3579 -25.9143 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.9425 -25.9129 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.9433 -25.0958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0630 -28.7768 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
44.5494 -27.1173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.2577 -27.5250 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
44.5483 -26.3001 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
45.9648 -27.1155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.6731 -27.5231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.6742 -28.3403 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
45.9659 -28.7438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.9650 -29.5575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.6715 -29.9689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
47.3804 -29.5606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
47.3830 -28.7408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
1 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
8 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 8 1 0
18 21 1 0
21 22 2 0
21 23 1 0
23 24 1 0
23 28 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
11 29 1 0
29 30 2 0
29 31 1 0
31 32 1 0
2 33 1 0
26 34 1 0
34 35 1 0
34 36 2 0
35 37 1 0
37 38 1 0
38 39 1 0
39 40 1 0
39 44 1 0
40 41 1 0
41 42 1 0
42 43 1 0
43 44 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 653.28Molecular Weight (Monoisotopic): 652.2169AlogP: 5.24#Rotatable Bonds: 9Polar Surface Area: 105.73Molecular Species: BASEHBA: 9HBD: 3#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 12.47CX Basic pKa: 8.64CX LogP: 6.43CX LogD: 5.16Aromatic Rings: 3Heavy Atoms: 44QED Weighted: 0.27Np Likeness Score: -1.67
References 1. Su Y, Li R, Ning X, Lin Z, Zhao X, Zhou J, Liu J, Jin Y, Yin Y.. (2019) Discovery of 2,4-diarylaminopyrimidine derivatives bearing dithiocarbamate moiety as novel FAK inhibitors with antitumor and anti-angiogenesis activities., 177 [PMID:31129452 ] [10.1016/j.ejmech.2019.05.048 ]